In line with this, BPTF inhibitor alone showed a certain anti-angiogenesis effect, while lumbrokinase combined with BPTF inhibitor showed a more significant effect on inhibiting angiogenesis in vitro, suggesting that the targeted inhibition of BPTF might become a new option for anti-tumor angiogenesis strategies. The gene discussed is BPTF; the disease is neoplasm.